Mr. Huang has over 27 years of executive leadership and investment experience in the Biotech Industry, with an MBA from Stanford University. Since the founding of the Company, Mr. Huang was appointed to be the Executive Chairman, to further grow the Company both as the largest investor’s representative (Kleiner Perkins) and also as a seasoned biotech executive. He is currently Managing Partner at Kleiner Perkins Greater China and Founding Partner at Panacea Venture, as well as Director for the board of multiple biotech companies, both privately and publically listed in the US, China, and Hong Kong.